JASMINE THOMPSON: Open Payments
NPI 1013386259 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,108 in 148 payments from 23 companies in 2025. Trend: 2023 $2,970 · 2024 $2,840 · 2025 $3,108
Food & beverage: $3,108
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 31 | $831 |
| GlaxoSmithKline, LLC. | 30 | $455 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $320 |
| GENZYME CORPORATION | 13 | $242 |
| Verona Pharma, Inc. | 17 | $230 |
| Viatris Specialty LLC | 9 | $225 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $114 |
| Baxter Healthcare | 4 | $96 |
| Insmed, Inc. | 5 | $93 |
| Mallinckrodt Hospital Products Inc. | 2 | $76 |
Products named: BEVESPI AEROSPHERE, DUPIXENT, TRELEGY ELLIPTA, OFEV, Ohtuvayre, YUPELRI, NUCALA, FASENRA.
Industry payments across OK — which companies pay providers there.
